Logo
x

Search

Subscribe Now

Based

Top 20 Generics Pharma Companies Based On 2019 Revenue

Top 20 Generics Pharma Companies Based On 2019 Revenue

  • December 10, 2020
Roche Reports Long-Term Benefits of Venclexta/Venclyxto Based Combination for R/R Chronic Lymphocytic Leukemia

Roche Reports Long-Term Benefits of Venclexta/Venclyxto Based Combination for R/R Chronic Lymphocytic Leukemia

  • December 7, 2020
Roche Expands its Collaboration with Immunomedics to Evaluate Tecentriq Based Combination Therapy in Urothelial and Non-Small Cell Lung Cancers

Roche Expands its Collaboration with Immunomedics to Evaluate Tecentriq Based Combination Therapy in Urothelial and Non-Small Cell...

  • July 14, 2020
Pfizer with its Partner BioNTech Receives the US FDA's Fast Track Designation for Two mRNA Based Therapies to Treat COVID-19

Pfizer with its Partner BioNTech Receives the US FDA's Fast Track Designation for Two mRNA Based Therapies to Treat COVID-19

  • July 13, 2020
Merck Receives the US FDA's Priority Review for Keytruda's (pembrolizumab) sBLA Based on Biomarker Regardless of Tumor Type

Merck Receives the US FDA's Priority Review for Keytruda's (pembrolizumab) sBLA Based on Biomarker Regardless of Tumor Type

  • April 7, 2020
Roche's Polivy (polatuzumab vedotin) Based Combination Regimen Receives EC's Approval for Patients with R/R Diffuse Large B-Cell Lymphoma

Roche's Polivy (polatuzumab vedotin) Based Combination Regimen Receives EC's Approval for Patients with R/R Diffuse Large B-Cell L...

  • January 21, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.